Brian Stuglik. Verastem
July 30, 2019 07:24 AM EDT
People

Ve­rastem taps board di­rec­tor and Eli Lil­ly vet Bri­an Stug­lik to right the com­mer­cial boat

Amber Tong

When Ve­rastem part­ed ways with CEO Robert For­rester days ago, the board in­di­cat­ed that they would be look­ing for a suc­ces­sor with the com­mer­cial chops …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times